{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T13:08:10Z","timestamp":1759410490380},"reference-count":46,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Adolescent Health"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.jadohealth.2012.07.017","type":"journal-article","created":{"date-parts":[[2012,9,25]],"date-time":"2012-09-25T00:52:00Z","timestamp":1348534320000},"page":"271-277","source":"Crossref","is-referenced-by-count":2,"title":["Use of MenACWY-CRM in Adolescents in the United States"],"prefix":"10.1016","volume":"52","author":[{"given":"Steven","family":"Black","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stan L.","family":"Block","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jadohealth.2012.07.017_bib1","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/MOP.0b013e32832c9668","article-title":"Neisseria meningitidis: Epidemiology, treatment and prevention in adolescents","volume":"21","author":"Brigham","year":"2009","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.jadohealth.2012.07.017_bib2","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0140-6736(06)67932-4","article-title":"Clinical recognition of meningococcal disease in children and adolescents","volume":"367","author":"Thompson","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.jadohealth.2012.07.017_bib3","first-page":"1","article-title":"Prevention and control of meningococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"54","author":"Bilukha","year":"2005","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.jadohealth.2012.07.017_bib4","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1086\/649209","article-title":"Changes in Neisseria meningitidis disease epidemiology in the United States, 1998-2007: Implications for prevention of meningococcal disease","volume":"50","author":"Cohn","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jadohealth.2012.07.017_bib5","unstructured":"Centers for Disease Control and Prevention (CDC). Factsheet: Meningococcal diseases and meningococcal vaccines, 2009. Available at: http:\/\/www.cdc.gov\/vaccines\/vpd-vac\/mening\/vac-mening-fs.htm#epi. Accessed September 24,\u00a02011."},{"key":"10.1016\/j.jadohealth.2012.07.017_bib6","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1056\/NEJM200105033441807","article-title":"Meningococcal disease","volume":"344","author":"Rosenstein","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jadohealth.2012.07.017_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/524041","article-title":"Economics of an adolescent meningococcal conjugate vaccination catch-up campaign in the United States","volume":"46","author":"Ortega-Sanchez","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"Suppl. 2","key":"10.1016\/j.jadohealth.2012.07.017_bib8","doi-asserted-by":"crossref","first-page":"B51","DOI":"10.1016\/j.vaccine.2009.04.063","article-title":"Global epidemiology of meningococcal disease","volume":"27","author":"Harrison","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.jadohealth.2012.07.017_bib9","unstructured":"Centers for Disease Control and Prevention (CDC). Active bacterial core surveillance report, emerging infections program network, Neisseria meningitidis, 2009. Available at: http:\/\/www.cdc.gov\/abcs\/reports-findings\/surv-reports.html. Accessed July 31,\u00a02011."},{"key":"10.1016\/j.jadohealth.2012.07.017_bib10","first-page":"21","article-title":"Laboratory-based surveillance for meningococcal disease in selected areas, United States, 1989-1991","volume":"42","author":"Jackson","year":"1993","journal-title":"MMWR CDC Surveill Summ"},{"key":"10.1016\/j.jadohealth.2012.07.017_bib11","series-title":"The changing epidemiology of meningococcal disease among U.S. children, adolescents and young adults","year":"2004"},{"key":"10.1016\/j.jadohealth.2012.07.017_bib12","first-page":"1","article-title":"Summary of notifiable diseases: United States, 2009","volume":"58","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jadohealth.2012.07.017_bib13","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1084\/jem.129.6.1307","article-title":"Human immunity to the meningococcus. I. The role of humoral antibodies","volume":"129","author":"Goldschneider","year":"1969","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jadohealth.2012.07.017_bib14","first-page":"72","article-title":"Updated recommendations for use of meningococcal conjugate vaccines \u2013 Advisory Committee on Immunization Practices (ACIP), 2010","volume":"60","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jadohealth.2012.07.017_bib15","first-page":"1018","article-title":"National, state, and local area vaccination coverage among adolescents aged 13-17 years\u2014United States, 2009","volume":"59","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jadohealth.2012.07.017_bib16","first-page":"1117","article-title":"National and state vaccination coverage among adolescents aged 13 through 17 years\u2014United States, 2010","volume":"60","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jadohealth.2012.07.017_bib17","first-page":"997","article-title":"National, state, and local area vaccination coverage among adolescents aged 13-17 years\u2014United States, 2008","volume":"58","year":"2009","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jadohealth.2012.07.017_bib18","series-title":"Menveo [Prescribing Information]","year":"2011"},{"key":"10.1016\/j.jadohealth.2012.07.017_bib19","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1086\/599117","article-title":"Phase III comparison of an investigational quadrivalent meningococcal conjugate vaccine with the licensed meningococcal ACWY conjugate vaccine in adolescents","volume":"49","author":"Jackson","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jadohealth.2012.07.017_bib20","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/INF.0b013e31818a0237","article-title":"A\u00a0randomized trial to determine the tolerability and immunogenicity of a quadrivalent meningococcal glycoconjugate vaccine in healthy adolescents","volume":"28","author":"Jackson","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jadohealth.2012.07.017_bib21","series-title":"Menomune [prescribing information]","year":"2011"},{"key":"10.1016\/j.jadohealth.2012.07.017_bib22","series-title":"Menactra [prescribing information]","year":"2011"},{"key":"10.1016\/j.jadohealth.2012.07.017_bib23","unstructured":"Jackson L, Reisinger K, Gill CJ, et\u00a0al. Persistence of immune response and boosting in adolescents five years after receiving Menveo or Menomune. Poster presented at the 2011 Joint Meeting of the Pediatric Academic Societies and Asian Society for Pediatric Research. Denver, CO, May 1,\u00a02011."},{"key":"10.1016\/j.jadohealth.2012.07.017_bib24","doi-asserted-by":"crossref","first-page":"881","DOI":"10.4161\/hv.6.11.12849","article-title":"Persistence of immune responses after a single dose of Novartis meningococcal serogroup A, C, W-135 and Y CRM-197 conjugate vaccine (Menveo(R)) or Menactra(R) among healthy adolescents","volume":"6","author":"Gill","year":"2010","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.jadohealth.2012.07.017_bib25","first-page":"1018","article-title":"Licensure of a meningococcal conjugate vaccine for children aged 2 through 10 years and updated booster dose guidance for adolescents and other persons at increased risk for meningococcal disease\u2013Advisory Committee on Immunization Practices (ACIP), 2011","volume":"60","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jadohealth.2012.07.017_bib26","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1542\/peds.2011-2380","article-title":"Meningococcal conjugate vaccines policy update: Booster dose recommendations","volume":"128","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.jadohealth.2012.07.017_bib27","first-page":"1705","article-title":"Recommendations on the use of quadrivalent human papillomavirus vaccine in males\u2014Advisory Committee on Immunization Practices (ACIP), 2011","volume":"60","year":"2011","journal-title":"MMWR"},{"key":"10.1016\/j.jadohealth.2012.07.017_bib28","first-page":"1","article-title":"Recommended immunization schedules for persons aged 0 through 18 years\u2014United States, 2011","volume":"60","author":"Centers for Disease Control and Prevention (CDC)","year":"2011","journal-title":"MMWR"},{"key":"10.1016\/j.jadohealth.2012.07.017_bib29","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1016\/j.vaccine.2010.02.045","article-title":"Safety and immunogenicity of one dose of MenACWY-CRM, an investigational quadrivalent meningococcal glycoconjugate vaccine, when administered to adolescents concomitantly or sequentially with Tdap and HPV vaccines","volume":"28","author":"Arguedas","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.jadohealth.2012.07.017_bib30","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1128\/CVI.00436-09","volume":"17","author":"Gasparini","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.jadohealth.2012.07.017_bib31","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1542\/peds.2009-2336","article-title":"Safety, tolerability, and immunogenicity of Gardasil given concomitantly with Menactra and Adacel","volume":"125","author":"Reisinger","year":"2010","journal-title":"Pediatrics"},{"key":"10.1016\/j.jadohealth.2012.07.017_bib32","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.vaccine.2010.11.057","article-title":"Immunogenicity and reactogenicity of co-administered tetanus-diphtheria-acellular pertussis (Tdap) and tetravalent meningococcal conjugate (MCV4) vaccines compared to their separate administration","volume":"29","author":"Weston","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.jadohealth.2012.07.017_bib33","first-page":"1128","article-title":"Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2011","volume":"26","author":"Centers for Disease Control and Prevention (CDC)","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jadohealth.2012.07.017_bib34","unstructured":"Centers for Disease Control and Prevention (CDC). GBS and Menactra meningococcal vaccine. Available at: http:\/\/www.cdc.gov\/vaccinesafety\/vaccines\/gbsfactsheet.html. Accessed September 23,\u00a02011."},{"key":"10.1016\/j.jadohealth.2012.07.017_bib35","first-page":"1120","article-title":"Update: Guillain-Barre syndrome among recipients of Menactra meningococcal conjugate vaccine\u2014United States, June 2005\u2013September 2006","volume":"55","author":"Centers for Disease Control and Prevention (CDC)","year":"2006","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jadohealth.2012.07.017_bib36","series-title":"Gardasil [prescribing information]","year":"2011"},{"key":"10.1016\/j.jadohealth.2012.07.017_bib37","series-title":"Cervarix [prescribing information]","year":"2011"},{"key":"10.1016\/j.jadohealth.2012.07.017_bib38","series-title":"Adacel [prescribing information]","year":"2010"},{"key":"10.1016\/j.jadohealth.2012.07.017_bib39","series-title":"Fluzone [prescribing information]","year":"2011"},{"key":"10.1016\/j.jadohealth.2012.07.017_bib40","series-title":"Fluvirin [prescribing information]","year":"2011"},{"key":"10.1016\/j.jadohealth.2012.07.017_bib41","first-page":"1","article-title":"General recommendations on immunization\u2014Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"60","author":"Centers for Disease Control and Prevention (CDC)","year":"2011","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.jadohealth.2012.07.017_bib42","unstructured":"World Health Organization (WHO). WHO Fact Sheet: Meningococcal meningitis. Available at: http:\/\/www.who.int\/mediacentre\/factsheets\/fs141\/en\/. Accessed June 15,\u00a02012."},{"key":"10.1016\/j.jadohealth.2012.07.017_bib43","series-title":"Meningococcal disease","author":"Centers for Disease Control and Prevention (CDC)","year":"2011"},{"key":"10.1016\/j.jadohealth.2012.07.017_bib44","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1542\/peds.2008-3645","article-title":"Booster vaccinations: Can immunologic memory outpace disease pathogenesis?","volume":"124","author":"Pichichero","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.jadohealth.2012.07.017_bib45","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nri2494","article-title":"Maintaining protection against invasive bacteria with protein-polysaccharide conjugate vaccines","volume":"9","author":"Pollard","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jadohealth.2012.07.017_bib46","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1016\/j.jadohealth.2009.12.004","article-title":"Barriers and potential solutions to increasing immunization rates in adolescents","volume":"46","author":"Kaplan","year":"2010","journal-title":"J\u00a0Adolesc Health"}],"container-title":["Journal of Adolescent Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1054139X12003230?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1054139X12003230?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T09:57:37Z","timestamp":1542707857000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1054139X12003230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S1054139X12003230"],"URL":"https:\/\/doi.org\/10.1016\/j.jadohealth.2012.07.017","relation":{},"ISSN":["1054-139X"],"issn-type":[{"value":"1054-139X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]}}}